Skip to Main Content

Author Details

Claudia Matter
University Hospital Zurich, University of Zurich
2000
10
9
PMIDPaper TitleJournal TitlePublished Year
32238882Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth.Oncogene2020
32238882Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth.Oncogene2020
25629959Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.PLoS Genet2015
25629959Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.PLoS Genet2015
23429573MAGE-C1/CT7 spontaneously triggers a CD4+ T-cell response in multiple myeloma patients.Leukemia2013
23687622Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma.Oncoimmunology2013
23429573MAGE-C1/CT7 spontaneously triggers a CD4+ T-cell response in multiple myeloma patients.Leukemia2013
23463003Aldara activates TLR7-independent immune defence.Nat Commun2013
24777966Spontaneous peripheral T-cell responses toward the tumor-associated antigen cyclin D1 in patients with clear cell renal cell carcinoma.Cancer Immunol Res2013
24777966Spontaneous peripheral T-cell responses toward the tumor-associated antigen cyclin D1 in patients with clear cell renal cell carcinoma.Cancer Immunol Res2013
23687622Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma.Oncoimmunology2013
23463003Aldara activates TLR7-independent immune defence.Nat Commun2013
20696919Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients.Proc Natl Acad Sci U S A2010
20696919Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients.Proc Natl Acad Sci U S A2010
11431358Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas.Cancer Res2001
11431358Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas.Cancer Res2001
11073802Genomic alterations in well-differentiated gastrointestinal and bronchial neuroendocrine tumors (carcinoids): marked differences indicating diversity in molecular pathogenesis.Am J Pathol2000
11021813Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells.Am J Pathol2000
11073802Genomic alterations in well-differentiated gastrointestinal and bronchial neuroendocrine tumors (carcinoids): marked differences indicating diversity in molecular pathogenesis.Am J Pathol2000
11021813Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells.Am J Pathol2000
  • 1 - 20 of 20

Recommended Authors

College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 0
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 1
University of Pisa
Career Start Year 2006
Number of shared co-authors 2
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 2
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 0
University of Turin
Career Start Year 1998
Number of shared co-authors 0
Weizmann Institute of Science
Career Start Year 1998
Number of shared co-authors 6
College of Medicine, The Catholic University of Korea
Career Start Year 1996
Number of shared co-authors 0
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 2
Cleveland Clinic.
Career Start Year 1994
Number of shared co-authors 1
University of South Carolina
Career Start Year 1993
Number of shared co-authors 1
Ludwig Institute for Cancer Research Ltd.
Career Start Year 1993
Number of shared co-authors 0
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Oncode Institute
Career Start Year 1993
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 1992
Number of shared co-authors 5
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 0
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year 1991
Number of shared co-authors 0
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 0
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 1
Convergence Institute, Johns Hopkins University
Career Start Year 1985
Number of shared co-authors 0
From Population Health Services (Chen)
Career Start Year 1984
Number of shared co-authors 2
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 1984
Number of shared co-authors 1
Spanish National Cancer Research Centre-CNIO
Career Start Year 1983
Number of shared co-authors 0
Queen's University
Career Start Year 1982
Number of shared co-authors 0
Saint John's Cancer Institute at Saint John's Health Center
Career Start Year 1982
Number of shared co-authors 2
Beth Israel Deaconess Medical Center and Harvard Medical School
Career Start Year 1981
Number of shared co-authors 1
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 0

Collaborators

University Hospital Zurich
Co-authored papers 4
University Hospital Zurich
Co-authored papers 4
Zurich University Hospital
Co-authored papers 2
University Hospital Zurich
Co-authored papers 2
Institute of Anatomy, University of Zurich
Co-authored papers 2
University Hospital Zurich
Co-authored papers 2
Northwestern University
Co-authored papers 1
Institut fur Biochemie, Friedrich-Alexander-Universitat Erlangen-Nurnberg
Co-authored papers 1
Moores Cancer Center, University of California
Co-authored papers 1
Netherlands Cancer Institute
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Institute of Anatomy, University of Zurich
Co-authored papers 1
University Hospital of Zurich
Co-authored papers 1
University of Zurich
Co-authored papers 1
Institute of Anatomy, University of Zurich
Co-authored papers 1
Co-authored papers 1
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Robert Wood Johnson Medical School, The State University of New Jersey
Co-authored papers 1
University Hospital Basel, University of Basel
Co-authored papers 1
Institute of Anatomy, University of Zurich
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1